Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 04 04:00PM ET
32.17
Dollar change
-0.10
Percentage change
-0.31
%
IndexRUT P/E- EPS (ttm)-6.33 Insider Own2.57% Shs Outstand55.95M Perf Week-2.13%
Market Cap1.81B Forward P/E- EPS next Y-5.87 Insider Trans-11.80% Shs Float54.75M Perf Month40.11%
Income-352.09M PEG- EPS next Q-1.64 Inst Own104.19% Short Float13.97% Perf Quarter44.71%
Sales26.82M P/S67.40 EPS this Y-5.19% Inst Trans-2.97% Short Ratio9.32 Perf Half Y17.28%
Book/sh14.50 P/B2.22 EPS next Y11.81% ROA-32.36% Short Interest7.65M Perf Year32.93%
Cash/sh13.83 P/C2.33 EPS next 5Y39.00% ROE-36.83% 52W Range19.80 - 35.50 Perf YTD44.45%
Dividend Est.- P/FCF- EPS past 5Y-0.98% ROI-40.56% 52W High-9.38% Beta0.84
Dividend TTM- Quick Ratio11.99 Sales past 5Y2.66% Gross Margin44.95% 52W Low62.52% ATR (14)1.53
Dividend Ex-Date- Current Ratio12.27 EPS Y/Y TTM-49.22% Oper. Margin-1459.52% RSI (14)68.37 Volatility5.48% 5.30%
Employees383 Debt/Eq0.09 Sales Y/Y TTM88.36% Profit Margin-1312.63% Recom1.67 Target Price40.67
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q-358.63% Payout- Rel Volume0.84 Prev Close32.27
Sales Surprise-10.38% EPS Surprise-3.77% Sales Q/Q64.80% EarningsFeb 15 BMO Avg Volume820.91K Price32.17
SMA2015.55% SMA5029.44% SMA20029.09% Trades Volume685,495 Change-0.31%
Date Action Analyst Rating Change Price Target Change
Feb-08-24Initiated Cantor Fitzgerald Overweight
Feb-03-23Initiated Piper Sandler Overweight $41
Nov-17-22Upgrade Goldman Sell → Neutral $17 → $32
Jul-27-22Upgrade SVB Leerink Mkt Perform → Outperform $33
Dec-03-21Initiated BofA Securities Buy $54
Jul-30-21Downgrade Goldman Neutral → Sell $58 → $39
Jul-01-21Initiated Raymond James Mkt Perform
Jun-10-21Initiated H.C. Wainwright Buy $88
Mar-01-21Upgrade SVB Leerink Mkt Perform → Outperform $50
Mar-01-21Downgrade JP Morgan Overweight → Neutral $64 → $54
Feb-26-24 03:12PM
Feb-23-24 10:45AM
Feb-22-24 07:00AM
Feb-20-24 08:24AM
Feb-16-24 09:38AM
10:15PM Loading…
Feb-15-24 10:15PM
08:25AM
07:59AM
07:00AM
Feb-08-24 10:00AM
Feb-02-24 07:00AM
Jan-24-24 07:02PM
Jan-11-24 07:15PM
Jan-08-24 07:00AM
Jan-04-24 11:19AM
07:47AM Loading…
07:47AM
Jan-03-24 04:05PM
02:46PM
02:01PM
10:09AM
09:26AM
06:58AM
06:40AM
06:30AM
Jan-02-24 07:00AM
Dec-09-23 07:00PM
Nov-21-23 10:56AM
Nov-20-23 07:00AM
Nov-03-23 12:10PM
11:06AM
09:32AM Loading…
Nov-02-23 09:32AM
09:05AM
07:10AM
07:00AM
Oct-19-23 07:00AM
Sep-07-23 11:30AM
Aug-29-23 07:00AM
Aug-10-23 06:08AM
Aug-04-23 05:32PM
09:10AM
06:04AM
Aug-03-23 11:53PM
07:55AM
06:54AM
06:35AM
06:30AM
Jul-18-23 09:55AM
Jul-17-23 09:55AM
Jul-13-23 07:00AM
Jun-28-23 09:40AM
Jun-27-23 01:47PM
Jun-26-23 02:23PM
06:30AM
Jun-12-23 09:55AM
Jun-05-23 07:00AM
May-30-23 09:45AM
May-25-23 09:55AM
07:00AM
May-11-23 10:00AM
May-09-23 09:55AM
May-08-23 07:55AM
May-05-23 10:50AM
May-04-23 11:23PM
08:25AM
07:00AM
Apr-25-23 07:00AM
Apr-19-23 07:00AM
Apr-13-23 07:00AM
Apr-12-23 08:00AM
Apr-09-23 01:19PM
Apr-03-23 07:00AM
Mar-15-23 11:44AM
Mar-11-23 09:10AM
Mar-05-23 05:20AM
Mar-02-23 08:26AM
Feb-28-23 07:00AM
Feb-24-23 12:00PM
11:49AM
Feb-23-23 08:45AM
08:38AM
07:00AM
Feb-09-23 09:40AM
Feb-02-23 07:00AM
Jan-15-23 08:56AM
Jan-08-23 08:00PM
Jan-03-23 05:57PM
Dec-24-22 10:07AM
Dec-21-22 08:00AM
Dec-11-22 07:00PM
Dec-10-22 06:30PM
Dec-06-22 07:00AM
Nov-30-22 08:00AM
Nov-17-22 05:52AM
Nov-11-22 11:03AM
Nov-10-22 04:01PM
Nov-09-22 05:36AM
Nov-04-22 12:20PM
Nov-03-22 09:00AM
08:25AM
08:00AM
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schenkein David PDirectorFeb 27Option Exercise31.6469,3292,193,570180,325Feb 29 04:05 PM
Schenkein David PDirectorFeb 27Sale34.6769,3292,403,592122,854Feb 29 04:05 PM
Schenkein David PDirectorFeb 26Option Exercise31.6420,411645,804143,265Feb 27 04:04 PM
Schenkein David PDirectorFeb 26Sale33.1920,411677,441122,854Feb 27 04:04 PM
Schenkein David PDirectorFeb 23Option Exercise31.6447,7311,510,209170,585Feb 27 04:04 PM
Schenkein David PDirectorFeb 23Sale33.0547,7311,577,510122,854Feb 27 04:04 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 20Sale26.6350413,4222,741Feb 22 05:43 PM
Gheuens SarahChief Medical OfficerFeb 14Sale25.1464216,14033,431Feb 14 05:53 PM
Burns James WilliamChief Legal OfficerFeb 14Sale25.1454513,70131,666Feb 14 05:51 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 14Sale25.142736,8633,245Feb 14 05:50 PM
Gheuens SarahChief Medical OfficerFeb 12Option Exercise0.002,162034,073Feb 14 05:53 PM
Burns James WilliamChief Legal OfficerFeb 12Option Exercise0.001,833032,211Feb 14 05:51 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 12Option Exercise0.0077703,518Feb 14 05:50 PM
FOUSE JACQUALYN ADirectorJan 24Sale21.6410,722232,024129,253Jan 24 04:22 PM
Goff BrianChief Executive OfficerJan 24Sale21.647,635165,22149,436Jan 24 04:20 PM
Jones CeciliaChief Financial OfficerJan 24Sale21.641,88640,81313,069Jan 24 04:23 PM
Burns James WilliamChief Legal OfficerJan 24Sale21.641,70836,96130,378Jan 24 04:25 PM
Gheuens SarahChief Medical OfficerJan 24Sale21.641,70836,96131,911Jan 24 04:24 PM
Milanova TsvetaChief Commercial OfficerJan 24Sale21.641,61835,01413,234Jan 24 04:19 PM
Burns James WilliamChief Legal OfficerJan 20Option Exercise0.005,750032,086Jan 24 04:25 PM
Gheuens SarahChief Medical OfficerJan 20Option Exercise0.005,750033,619Jan 24 04:24 PM
Jones CeciliaChief Financial OfficerJan 20Option Exercise0.005,380014,955Jan 24 04:23 PM
FOUSE JACQUALYN ADirectorJan 20Option Exercise0.0023,9000139,975Jan 24 04:22 PM
Goff BrianChief Executive OfficerJan 20Option Exercise0.0017,018057,071Jan 24 04:20 PM
Milanova TsvetaChief Commercial OfficerJan 20Option Exercise0.005,448014,852Jan 24 04:19 PM
Goff BrianChief Executive OfficerJan 09Sale22.9912,066277,39740,053Jan 09 04:28 PM
FOUSE JACQUALYN ADirectorJan 09Sale22.998,391192,909116,075Jan 09 04:26 PM
Gheuens SarahChief Medical OfficerJan 09Sale22.991,78941,12927,869Jan 09 04:22 PM
Burns James WilliamChief Legal OfficerJan 09Sale22.991,16326,73726,336Jan 09 04:25 PM
Goff BrianChief Executive OfficerJan 05Option Exercise0.0025,527052,119Jan 09 04:28 PM
FOUSE JACQUALYN ADirectorJan 05Option Exercise0.0017,5000124,466Jan 09 04:26 PM
Burns James WilliamChief Legal OfficerJan 05Option Exercise0.003,250027,499Jan 09 04:25 PM
Gheuens SarahChief Medical OfficerJan 05Option Exercise0.005,000029,658Jan 09 04:22 PM
Milanova TsvetaChief Commercial OfficerJan 05Sale22.322,90264,7739,404Jan 05 04:10 PM
Milanova TsvetaChief Commercial OfficerJan 03Option Exercise0.008,475012,306Jan 05 04:10 PM
Jones CeciliaChief Financial OfficerSep 28Sale24.792,17954,0179,575Sep 28 04:02 PM
Jones CeciliaChief Financial OfficerSep 26Option Exercise0.007,472011,754Sep 28 04:02 PM
Burns James WilliamChief Legal OfficerAug 17Sale26.286,395168,06123,890Aug 21 04:03 PM
Ballal Rahul D.DirectorAug 11Option Exercise0.002,30202,302Aug 15 04:06 PM
Smith CynthiaDirectorAug 11Option Exercise0.002,30202,302Aug 15 04:04 PM
Foster-Cheek Kaye IDirectorAug 09Option Exercise18.0925,000452,25036,524Aug 11 04:04 PM
Foster-Cheek Kaye IDirectorAug 09Sale25.9625,000648,88811,524Aug 11 04:04 PM
Goff BrianChief Executive OfficerAug 08Option Exercise0.0022,691036,770Aug 10 04:07 PM
Goff BrianChief Executive OfficerAug 08Sale25.4810,178259,33526,592Aug 10 04:07 PM
Washburn Theodore James Jr.Principal Accounting OfficerAug 07Sale25.392,91874,0962,741Aug 09 04:04 PM
Washburn Theodore James Jr.Principal Accounting OfficerAug 01Option Exercise0.004,15006,891Aug 02 04:02 PM
Washburn Theodore James Jr.Principal Accounting OfficerAug 01Sale26.261,23232,3525,659Aug 02 04:02 PM
Goff BrianChief Executive OfficerJun 30Sale28.3611,449324,69414,079Jun 30 04:05 PM
FOUSE JACQUALYN ADirectorJun 30Sale28.3610,718303,962106,966Jun 30 04:07 PM
Burns James WilliamChief Legal OfficerJun 30Sale28.361,70748,41130,285Jun 30 04:09 PM
Gheuens SarahChief Medical OfficerJun 30Sale28.361,70748,41124,159Jun 30 04:06 PM
Milanova TsvetaChief Commercial OfficerJun 30Sale28.361,61845,8863,831Jun 30 04:02 PM
Jones CeciliaChief Financial OfficerJun 30Sale28.361,59745,2913,783Jun 30 04:03 PM
Burns James WilliamChief Legal OfficerJun 28Option Exercise0.005,750031,992Jun 30 04:09 PM
FOUSE JACQUALYN ADirectorJun 28Option Exercise0.0023,9000117,684Jun 30 04:07 PM
Goff BrianChief Executive OfficerJun 28Option Exercise0.0025,528025,528Jun 30 04:05 PM
Gheuens SarahChief Medical OfficerJun 28Option Exercise0.005,750025,866Jun 30 04:06 PM
Jones CeciliaChief Financial OfficerJun 28Option Exercise0.005,38005,380Jun 30 04:03 PM
Milanova TsvetaChief Commercial OfficerJun 28Option Exercise0.005,44905,449Jun 30 04:02 PM
Foster-Cheek Kaye IDirectorJun 21Option Exercise0.004,975011,524Jun 23 04:38 PM
Ho MaykinDirectorJun 21Option Exercise0.004,975011,524Jun 23 04:37 PM
Scadden DavidDirectorJun 21Option Exercise0.004,975012,095Jun 23 04:36 PM
Schenkein David PDirectorJun 21Option Exercise0.004,9750122,854Jun 23 04:34 PM
FOUSE JACQUALYN ADirectorApr 08Option Exercise0.0015,933098,515Apr 12 04:17 PM
Schenkein David PDirectorApr 03Option Exercise9.0516,363148,085134,242Apr 05 04:03 PM
Schenkein David PDirectorApr 03Sale22.8516,363373,895117,879Apr 05 04:03 PM
Schenkein David PDirectorMar 27Option Exercise9.0520,000181,000137,879Mar 29 09:30 PM
Schenkein David PDirectorMar 27Sale22.1520,000443,000117,879Mar 29 09:30 PM
Schenkein David PDirectorMar 13Option Exercise9.0520,000181,000137,879Mar 15 05:11 PM
Schenkein David PDirectorMar 13Sale22.4920,000449,817117,879Mar 15 05:11 PM